New date for publication of year-end results and updated financial calendar.

08:30 / 14 February 2018 Brighter Press release

The publication of Brighter's year-end report 2017 is moved from February 23 to March 23 due to implementation of a new accounting principle (IFRS). The change is being made in order to prepare the company for a transfer to a regulated marketplace.

- Our ambition is to become a leading player in the global market, and we intend to strengthen the company in all ways necessary to achieve this. Switching to the IFRS accounting principle is a part of our preparations to meet the requirements for transferring from Nasdaq First North to a regulated market such as Nasdaq's main list. A list change to a regulated market opens up for new types of investors, such as institutional investors and international stakeholders, while also strengthening the stock's liquidity, says Truls Sjöstedt, Brighter's CEO and founder.

Additionally, the company is moving the publication of the Interim Report January-March 2018 from April 20 to May 15, 2018.

Financial calendar 2017/2018:

March 23, 2018                  Year-end report 2017

May 15, 2018                      Interim report January-March 2018

August 24, 2018                  Half-year report January-June 2018

November 15, 2018            Interim report January-September 2018

For more information, please contact:

Truls Sjöstedt, CEO            
Tel: +46 709 73 46 00            

Ann Zetterberg, CFO            
Tel: +46 708 37 21 23           

About Brighter
Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of the most serious healthcare problems: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop™ - is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and close associates, healthcare providers, research, pharmaceutical industry and society.

The Company's shares are listed on NASDAQOMX First North/BRIG ( Brighter's Certified Adviser on Nasdaq OMX First North is Remium Nordic Holding AB +46 (0)8 - 454 32 50,,

This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08:30 CET on February 14, 2018.

Show as PDF

Show original from Cision


This information was distributed by Cision